Zobrazeno 1 - 10
of 31
pro vyhledávání: '"Zha, Jiping"'
Autor:
Xi Y; NGM Biopharmaceuticals, South San Francisco, CA 94080, USA., Song B; NGM Biopharmaceuticals, South San Francisco, CA 94080, USA., Ngan I; NGM Biopharmaceuticals, South San Francisco, CA 94080, USA., Solloway MJ; NGM Biopharmaceuticals, South San Francisco, CA 94080, USA., Humphrey M; NGM Biopharmaceuticals, South San Francisco, CA 94080, USA., Wang Y; NGM Biopharmaceuticals, South San Francisco, CA 94080, USA., Mondal K; NGM Biopharmaceuticals, South San Francisco, CA 94080, USA., Wu H; NGM Biopharmaceuticals, South San Francisco, CA 94080, USA., Liu W; NGM Biopharmaceuticals, South San Francisco, CA 94080, USA., Lindhout DA; NGM Biopharmaceuticals, South San Francisco, CA 94080, USA., Li D; NGM Biopharmaceuticals, South San Francisco, CA 94080, USA., Matern H; NGM Biopharmaceuticals, South San Francisco, CA 94080, USA., Kekatpure A; NGM Biopharmaceuticals, South San Francisco, CA 94080, USA., Haldankar R; NGM Biopharmaceuticals, South San Francisco, CA 94080, USA., Kaplan DD; NGM Biopharmaceuticals, South San Francisco, CA 94080, USA., Yang H; NGM Biopharmaceuticals, South San Francisco, CA 94080, USA., Pedersen O; NGM Biopharmaceuticals, South San Francisco, CA 94080, USA., Chen A; NGM Biopharmaceuticals, South San Francisco, CA 94080, USA., Zhou M; NGM Biopharmaceuticals, South San Francisco, CA 94080, USA., Winans B; NGM Biopharmaceuticals, South San Francisco, CA 94080, USA., Guo W; NGM Biopharmaceuticals, South San Francisco, CA 94080, USA., Kutach A; NGM Biopharmaceuticals, South San Francisco, CA 94080, USA., Fanget M; NGM Biopharmaceuticals, South San Francisco, CA 94080, USA., Fox M; NGM Biopharmaceuticals, South San Francisco, CA 94080, USA., Tang J; NGM Biopharmaceuticals, South San Francisco, CA 94080, USA., Zha J; NGM Biopharmaceuticals, South San Francisco, CA 94080, USA., Younis H; NGM Biopharmaceuticals, South San Francisco, CA 94080, USA., Shen D; NGM Biopharmaceuticals, South San Francisco, CA 94080, USA., DePaoli A; NGM Biopharmaceuticals, South San Francisco, CA 94080, USA., Tian H; NGM Biopharmaceuticals, South San Francisco, CA 94080, USA., Liu Z; NGM Biopharmaceuticals, South San Francisco, CA 94080, USA. Electronic address: zhliu74@gmail.com.
Publikováno v:
Cell reports [Cell Rep] 2022 May 31; Vol. 39 (9), pp. 110872.
Autor:
Bosco EE; Oncology Research, MedImmune, LLC, Gaithersburg, Maryland, United States of America., Christie RJ; Antibody Discovery and Protein Engineering, MedImmune, LLC, Gaithersburg, Maryland, United States of America., Carrasco R; Oncology Research, MedImmune, LLC, Gaithersburg, Maryland, United States of America., Sabol D; Oncology Research, MedImmune, LLC, Gaithersburg, Maryland, United States of America., Zha J; Pathology, MedImmune, LLC, Gaithersburg, Maryland, United States of America.; Translational Sciences, NGM Biopharmaceuticals, South San Francisco, California, United States of America., DaCosta K; Pathology, MedImmune, LLC, Gaithersburg, Maryland, United States of America., Brown L; Pathology, MedImmune, Ltd, Cambridge, United Kingdom., Kennedy M; Oncology Research, MedImmune, LLC, Gaithersburg, Maryland, United States of America., Meekin J; Oncology Research, MedImmune, LLC, Gaithersburg, Maryland, United States of America., Phipps S; Antibody Discovery and Protein Engineering, MedImmune, LLC, Gaithersburg, Maryland, United States of America., Ayriss J; Antibody Discovery and Protein Engineering, MedImmune, LLC, Gaithersburg, Maryland, United States of America.; Department of Global Biotherapeutics, Pfizer, Cambridge, Massachusetts, United States of America., Du Q; Antibody Discovery and Protein Engineering, MedImmune, LLC, Gaithersburg, Maryland, United States of America., Bezabeh B; Antibody Discovery and Protein Engineering, MedImmune, LLC, Gaithersburg, Maryland, United States of America.; Research, Salubris Biotherapeutics, Gaithersburg, Maryland, United States of America., Chowdhury P; Antibody Discovery and Protein Engineering, MedImmune, LLC, Gaithersburg, Maryland, United States of America.; Biologics Discovery, Sanofi Genzyme, Cambridge, MA, United States of America., Breen S; Oncology Research, MedImmune, LLC, Gaithersburg, Maryland, United States of America., Chen C; Oncology Research, MedImmune, LLC, Gaithersburg, Maryland, United States of America., Reed M; Biologics Safety Assessment, MedImmune, LLC, Gaithersburg, Maryland, United States of America., Hinrichs M; Biologics Safety Assessment, MedImmune, LLC, Gaithersburg, Maryland, United States of America., Zhong H; Oncology Research, MedImmune, LLC, Gaithersburg, Maryland, United States of America., Xiao Z; Oncology Research, MedImmune, LLC, Gaithersburg, Maryland, United States of America., Dixit R; Biologics Safety Assessment, MedImmune, LLC, Gaithersburg, Maryland, United States of America., Herbst R; Oncology Research, MedImmune, LLC, Gaithersburg, Maryland, United States of America., Tice DA; Oncology Research, MedImmune, LLC, Gaithersburg, Maryland, United States of America.
Publikováno v:
Oncotarget [Oncotarget] 2018 May 01; Vol. 9 (33), pp. 22960-22975. Date of Electronic Publication: 2018 May 01 (Print Publication: 2018).
Autor:
Steele KE; MedImmune, One MedImmune Way, Gaithersburg, MD, 20878, USA. SteeleK@MedImmune.com., Tan TH; Professional Services, Definiens AG, Bernhard-Wicki-Strasse 5, 80636, Munich, Germany., Korn R; Professional Services, Definiens AG, Bernhard-Wicki-Strasse 5, 80636, Munich, Germany., Dacosta K; MedImmune, One MedImmune Way, Gaithersburg, MD, 20878, USA., Brown C; MedImmune, One MedImmune Way, Gaithersburg, MD, 20878, USA., Kuziora M; MedImmune, One MedImmune Way, Gaithersburg, MD, 20878, USA., Zimmermann J; Professional Services, Definiens AG, Bernhard-Wicki-Strasse 5, 80636, Munich, Germany., Laffin B; Professional Services, Definiens AG, Bernhard-Wicki-Strasse 5, 80636, Munich, Germany.; Present address: Brian Laffin-BMS US Medical Oncology, 3401 Princeton Pike, Lawrence Township, NJ, 08648, USA., Widmaier M; Professional Services, Definiens AG, Bernhard-Wicki-Strasse 5, 80636, Munich, Germany., Rognoni L; Professional Services, Definiens AG, Bernhard-Wicki-Strasse 5, 80636, Munich, Germany., Cardenes R; Professional Services, Definiens AG, Bernhard-Wicki-Strasse 5, 80636, Munich, Germany., Schneider K; Professional Services, Definiens AG, Bernhard-Wicki-Strasse 5, 80636, Munich, Germany., Boutrin A; MedImmune, One MedImmune Way, Gaithersburg, MD, 20878, USA., Martin P; MedImmune, One MedImmune Way, Gaithersburg, MD, 20878, USA., Zha J; MedImmune, One MedImmune Way, Gaithersburg, MD, 20878, USA.; Present address: Jiping Zha - NGM Biopharmaceuticals, 333 Oyster Point Boulevard, South San Francisco, CA, 94080, USA., Wiestler T; Professional Services, Definiens AG, Bernhard-Wicki-Strasse 5, 80636, Munich, Germany.
Publikováno v:
Journal for immunotherapy of cancer [J Immunother Cancer] 2018 Mar 06; Vol. 6 (1), pp. 20. Date of Electronic Publication: 2018 Mar 06.
Autor:
Hendry S; Departments of *Pathology §§§Medical Oncology, Peter MacCallum Cancer Centre, Melbourne †The Sir Peter MacCallum Department of Oncology Departments of **Pathology ∥∥Medicine, University of Melbourne ¶¶Department of Anatomical Pathology, Royal Melbourne Hospital, Parkville #Department of Anatomical Pathology, St Vincent's Hospital Melbourne, Fitzroy ††Department of Medical Oncology, Austin Health ‡‡Olivia Newton-John Cancer Research Institute, Heidelberg §§School of Cancer Medicine, La Trobe University, Bundoora §§§§§Centre for Clinical Research and School of Medicine, The University of Queensland ∥∥∥∥∥Pathology Queensland, Royal Brisbane and Women's Hospital, Brisbane §§§§§§§§§§The Cancer Research Program, Garvan Institute of Medical Research, Darlinghurst ∥∥∥∥∥∥∥∥∥∥Australian Clinical Labs, Bella Vista ‡‡‡‡‡‡‡‡‡‡‡‡Directorate of Surgical Pathology, SA Pathology §§§§§§§§§§§§Discipline of Medicine, Adelaide University, Adelaide, Australia ***********Department of Surgical Oncology, Netherlands Cancer Institute †††††††††††††Department of Pathology ##Divisions of Diagnostic Oncology & Molecular Pathology, Netherlands Cancer Institute-Antoni van Leeuwenhoek, Amsterdam, The Netherlands ###Université Paris-Est ****INSERM, UMR 955 ††††Département de pathologie, APHP, Hôpital Henri-Mondor, Créteil ∥∥∥∥∥∥∥∥∥Service de Biostatistique et d'Epidémiologie, Gustave Roussy, CESP, Inserm U1018, Université-Paris Sud, Université Paris-Saclay ¶¶¶¶¶¶¶¶¶¶INSERM Unit U981, and Department of Medical Oncology, Gustave Roussy, Villejuif ##########Faculté de Médecine, Université Paris Sud, Kremlin-Bicêtre †††††††Department of Surgical Pathology and Biopathology, Jean Perrin Comprehensive Cancer Centre ‡‡‡‡‡‡‡University of Auvergne UMR1240, Clermont-Ferrand, France ‡‡‡‡Department of Medicine, Clinical Division of Oncology §§§§Institute of Neurology, Comprehensive Cancer Centre Vienna, Medical University of Vienna, Vienna ††††††††††††††Institute of Pathology, Medical University of Graz, Austria ∥∥∥∥European Institute of Oncology ¶¶¶¶School of Medicine ######Department of Pathology, Istituto Europeo di Oncologia, University of Milan, Milan ¶¶¶¶¶¶¶¶¶¶¶¶¶Department of Surgery, Oncology and Gastroenterology, University of Padova #############Medical Oncology 2, Veneto Institute of Oncology IOV-IRCCS, Padua, Italy †††††Molecular Oncology Group, Vall d'Hebron Institute of Oncology, Barcelona †††††††††††Pathology Department, IIS-Fundacion Jimenez Diaz, UAM, Madrid, Spain §Department of Pathology and TCRU, GZA ¶¶¶Department of Pathology, GZA Ziekenhuizen, Antwerp ∥Laboratory of Experimental Urology, Department of Development and Regeneration, KU Leuven ‡‡‡‡‡‡‡‡‡‡‡Department of Pathology, University Hospital Leuven, Leuven, Belgium ¶Department of Pathology, AZ Klina, Brasschaat ††††††Department of Pathology, GZA Ziekenhuizen, Sint-Augustinus, Wilrijk ∥∥∥Molecular Immunology Unit ‡‡‡‡‡‡Department of Medical Oncology, Institut Jules Bordet, Université Libre de Bruxelles ‡Breast Cancer Translational Research Laboratory/Breast International Group, Institut Jules Bordet **************European Organisation for Research and Treatment of Cancer (EORTC) Headquarters *******Department of Pathology, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium §§§§§§§Department of Surgery, Kansai Medical School, Hirakata, Japan #######Severance Biomedical Science Institute and Department of Medical Oncology, Yonsei University College of Medicine, Seoul, South Korea ∥∥∥∥∥∥∥∥Tumor Pathology Department, Maria Sklodowska-Curie Memorial Cancer Center ¶¶¶¶¶¶¶¶Institute of Oncology, Gliwice Branch, Gliwice, Poland ‡‡‡‡‡‡‡‡‡‡‡‡‡‡Pathology and Tissue Analytics, Roche Innovation Centre Munich, Penzberg †††††††††Institute of Pathology, Charité Universitätsmedizin Berlin ‡‡‡‡‡‡‡‡‡VMscope GmbH, Berlin ¶¶¶¶¶¶¶¶¶German Breast Group GmbH, Neu-Isenburg, Germany **********Trev & Joyce Deeley Research Centre, British Columbia Cancer Agency ††††††††††Department of Biochemistry and Microbiology, University of Victoria, Victoria Departments of ‡‡‡‡‡‡‡‡‡‡Medical Genetics #########Pathology and Laboratory Medicine ¶¶¶¶¶¶¶¶¶¶¶Department of Pathology and Laboratory Medicine, Genetic Pathology Evaluation Centre, University of British Columbia, Vancouver, BC ###########Department of Pathology and Laboratory Medicine, University of Ottawa, Ottawa, Canada §§§§§§§§§§§Department of Pathology and Laboratory Medicine, Weill Cornell Medical College, Doha, Qatar ‡‡‡‡‡‡‡‡Department of Pathology and Laboratory Medicine, Rhode Island Hospital and Lifespan Medical Center §§§§§§§§Warren Alpert Medical School of Brown University, Providence ¶¶¶¶¶National Surgical Adjuvant Breast and Bowel Project Operations Center/NRG Oncology, Pittsburgh, PA †††Breast Cancer Research Program, Vanderbilt Ingram Cancer Center, Vanderbilt University Departments of ‡‡‡Pathology, Microbiology and Immunology ########Department of Medicine, Vanderbilt University Medical Centre *********Vanderbilt Ingram Cancer Center, Nashville §§§§§§§§§Department of Pathology, Yale University School of Medicine, New Haven ∥∥∥∥∥∥∥∥∥∥∥Department of Oncology, Montefiore Medical Centre, Albert Einstein College of Medicine ∥∥∥∥∥∥∥Montefiore Medical Center ¶¶¶¶¶¶¶The Albert Einstein College of Medicine, Bronx, NY ********Department of Pathology, Brigham and Women's Hospital #####Cancer Research Institute and Department of Pathology, Beth Israel Deaconess Cancer Center ******Harvard Medical School ¶¶¶¶¶¶¶¶¶¶¶¶Division of Hematology-Oncology, Beth Israel Deaconess Medical Center ††††††††Department of Cancer Biology ‡‡‡‡‡‡‡‡‡‡‡‡‡Dana-Farber Cancer Institute, Boston, MA ∥∥∥∥∥∥∥∥∥∥∥∥∥Department of Medicine, Division of Medical Oncology, University of Colorado Anschutz Medical Campus, Aurora, CO ‡‡‡‡‡Department of Cancer Biology, Mayo Clinic, Jacksonville, FL ∥∥∥∥∥∥Department of Pathology and Laboratory Medicine, Indiana University, Indianapolis, IN ¶¶¶¶¶¶Cancer Immunotherapy Trials Network, Central Laboratory and Program in Immunology, Fred Hutchinson Cancer Research Center, Seattle, WA ††††††††††††Department of Pathology, New York University Langone Medical Centre ############New York University Medical School *************Perlmutter Cancer Center §§§§§§§§§§§§§Pulmonary Pathology, New York University Center for Biospecimen Research and Development, New York University ***************Department of Pathology, Memorial Sloan-Kettering Cancer Center ####Departments of Radiation Oncology and Pathology, Weill Cornell Medicine, New York, NY *****Department of Pathology, University of Texas M.D. Anderson Cancer Center, Houston, TX ∥∥∥∥∥∥∥∥∥∥∥∥Pathology Department, Stanford University Medical Centre, Stanford ∥∥∥∥∥∥∥∥∥∥∥∥∥∥Department of Pathology, Stanford University, Palo Alto ***Department of Pathology, School of Medicine, University of California, San Diego §§§§§§§§§§§§§§Research Pathology, Genentech Inc., South San Francisco, CA *************Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda ¶¶¶¶¶¶¶¶¶¶¶¶¶¶Translational Sciences, MedImmune, Gaithersberg, MD §§§§§§Academic Medical Innovation, Novartis Pharmaceuticals Corporation, East Hanover ##############Translational Medicine, Merck & Co. Inc., Kenilworth, NJ., Salgado R, Gevaert T, Russell PA, John T, Thapa B, Christie M, van de Vijver K, Estrada MV, Gonzalez-Ericsson PI, Sanders M, Solomon B, Solinas C, Van den Eynden GGGM, Allory Y, Preusser M, Hainfellner J, Pruneri G, Vingiani A, Demaria S, Symmans F, Nuciforo P, Comerma L, Thompson EA, Lakhani S, Kim SR, Schnitt S, Colpaert C, Sotiriou C, Scherer SJ, Ignatiadis M, Badve S, Pierce RH, Viale G, Sirtaine N, Penault-Llorca F, Sugie T, Fineberg S, Paik S, Srinivasan A, Richardson A, Wang Y, Chmielik E, Brock J, Johnson DB, Balko J, Wienert S, Bossuyt V, Michiels S, Ternes N, Burchardi N, Luen SJ, Savas P, Klauschen F, Watson PH, Nelson BH, Criscitiello C, O'Toole S, Larsimont D, de Wind R, Curigliano G, André F, Lacroix-Triki M, van de Vijver M, Rojo F, Floris G, Bedri S, Sparano J, Rimm D, Nielsen T, Kos Z, Hewitt S, Singh B, Farshid G, Loibl S, Allison KH, Tung N, Adams S, Willard-Gallo K, Horlings HM, Gandhi L, Moreira A, Hirsch F, Dieci MV, Urbanowicz M, Brcic I, Korski K, Gaire F, Koeppen H, Lo A, Giltnane J, Rebelatto MC, Steele KE, Zha J, Emancipator K, Juco JW, Denkert C, Reis-Filho J, Loi S, Fox SB
Publikováno v:
Advances in anatomic pathology [Adv Anat Pathol] 2017 Nov; Vol. 24 (6), pp. 311-335.
Autor:
Hendry S; Departments of *Pathology §§§Medical Oncology, Peter MacCallum Cancer Centre, Melbourne †The Sir Peter MacCallum Department of Oncology Departments of **Pathology ∥∥Medicine, University of Melbourne ¶¶Department of Anatomical Pathology, Royal Melbourne Hospital, Parkville #Department of Anatomical Pathology, St Vincent's Hospital Melbourne, Fitzroy ††Department of Medical Oncology, Austin Health ‡‡Olivia Newton-John Cancer Research Institute, Heidelberg §§School of Cancer Medicine, La Trobe University, Bundoora §§§§§Centre for Clinical Research and School of Medicine, The University of Queensland ∥∥∥∥∥Pathology Queensland, Royal Brisbane and Women's Hospital, Brisbane §§§§§§§§§§The Cancer Research Program, Garvan Institute of Medical Research, Darlinghurst ∥∥∥∥∥∥∥∥∥∥Australian Clinical Labs, Bella Vista ‡‡‡‡‡‡‡‡‡‡‡‡Directorate of Surgical Pathology, SA Pathology §§§§§§§§§§§§Discipline of Medicine, Adelaide University, Adelaide, Australia ***********Department of Surgical Oncology, Netherlands Cancer Institute †††††††††††††Department of Pathology ##Divisions of Diagnostic Oncology & Molecular Pathology, Netherlands Cancer Institute-Antoni van Leeuwenhoek, Amsterdam, The Netherlands ###Université Paris-Est ****INSERM, UMR 955 ††††Département de pathologie, APHP, Hôpital Henri-Mondor, Créteil ∥∥∥∥∥∥∥∥∥Service de Biostatistique et d'Epidémiologie, Gustave Roussy, CESP, Inserm U1018, Université-Paris Sud, Université Paris-Saclay ¶¶¶¶¶¶¶¶¶¶INSERM Unit U981, and Department of Medical Oncology, Gustave Roussy, Villejuif ##########Faculté de Médecine, Université Paris Sud, Kremlin-Bicêtre †††††††Department of Surgical Pathology and Biopathology, Jean Perrin Comprehensive Cancer Centre ‡‡‡‡‡‡‡University of Auvergne UMR1240, Clermont-Ferrand, France ‡‡‡‡Department of Medicine, Clinical Division of Oncology §§§§Institute of Neurology, Comprehensive Cancer Centre Vienna, Medical University of Vienna, Vienna ††††††††††††††Institute of Pathology, Medical University of Graz, Austria ∥∥∥∥European Institute of Oncology ¶¶¶¶School of Medicine ######Department of Pathology, Istituto Europeo di Oncologia, University of Milan, Milan ¶¶¶¶¶¶¶¶¶¶¶¶¶Department of Surgery, Oncology and Gastroenterology, University of Padova #############Medical Oncology 2, Veneto Institute of Oncology IOV-IRCCS, Padua, Italy †††††Molecular Oncology Group, Vall d'Hebron Institute of Oncology, Barcelona †††††††††††Pathology Department, IIS-Fundacion Jimenez Diaz, UAM, Madrid, Spain §Department of Pathology and TCRU, GZA ¶¶¶Department of Pathology, GZA Ziekenhuizen, Antwerp ∥Laboratory of Experimental Urology, Department of Development and Regeneration, KU Leuven ‡‡‡‡‡‡‡‡‡‡‡Department of Pathology, University Hospital Leuven, Leuven, Belgium ¶Department of Pathology, AZ Klina, Brasschaat ††††††Department of Pathology, GZA Ziekenhuizen, Sint-Augustinus, Wilrijk ∥∥∥Molecular Immunology Unit ‡‡‡‡‡‡Department of Medical Oncology, Institut Jules Bordet, Université Libre de Bruxelles ‡Breast Cancer Translational Research Laboratory/Breast International Group, Institut Jules Bordet **************European Organisation for Research and Treatment of Cancer (EORTC) Headquarters *******Department of Pathology, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium §§§§§§§Department of Surgery, Kansai Medical School, Hirakata, Japan #######Severance Biomedical Science Institute and Department of Medical Oncology, Yonsei University College of Medicine, Seoul, South Korea ∥∥∥∥∥∥∥∥Tumor Pathology Department, Maria Sklodowska-Curie Memorial Cancer Center ¶¶¶¶¶¶¶¶Institute of Oncology, Gliwice Branch, Gliwice, Poland ‡‡‡‡‡‡‡‡‡‡‡‡‡‡Pathology and Tissue Analytics, Roche Innovation Centre Munich, Penzberg †††††††††Institute of Pathology, Charité Universitätsmedizin Berlin ‡‡‡‡‡‡‡‡‡VMscope GmbH, Berlin ¶¶¶¶¶¶¶¶¶German Breast Group GmbH, Neu-Isenburg, Germany **********Trev & Joyce Deeley Research Centre, British Columbia Cancer Agency ††††††††††Department of Biochemistry and Microbiology, University of Victoria, Victoria Departments of ‡‡‡‡‡‡‡‡‡‡Medical Genetics #########Pathology and Laboratory Medicine ¶¶¶¶¶¶¶¶¶¶¶Department of Pathology and Laboratory Medicine, Genetic Pathology Evaluation Centre, University of British Columbia, Vancouver, BC ###########Department of Pathology and Laboratory Medicine, University of Ottawa, Ottawa, Canada §§§§§§§§§§§Department of Pathology and Laboratory Medicine, Weill Cornell Medical College, Doha, Qatar ‡‡‡‡‡‡‡‡Department of Pathology and Laboratory Medicine, Rhode Island Hospital and Lifespan Medical Center §§§§§§§§Warren Alpert Medical School of Brown University, Providence ¶¶¶¶¶National Surgical Adjuvant Breast and Bowel Project Operations Center/NRG Oncology, Pittsburgh, PA †††Breast Cancer Research Program, Vanderbilt Ingram Cancer Center, Vanderbilt University Departments of ‡‡‡Pathology, Microbiology and Immunology ########Department of Medicine, Vanderbilt University Medical Centre *********Vanderbilt Ingram Cancer Center, Nashville §§§§§§§§§Department of Pathology, Yale University School of Medicine, New Haven ∥∥∥∥∥∥∥∥∥∥∥Department of Oncology, Montefiore Medical Centre, Albert Einstein College of Medicine ∥∥∥∥∥∥∥Montefiore Medical Center ¶¶¶¶¶¶¶The Albert Einstein College of Medicine, Bronx, NY ********Department of Pathology, Brigham and Women's Hospital #####Cancer Research Institute and Department of Pathology, Beth Israel Deaconess Cancer Center ******Harvard Medical School ¶¶¶¶¶¶¶¶¶¶¶¶Division of Hematology-Oncology, Beth Israel Deaconess Medical Center ††††††††Department of Cancer Biology ‡‡‡‡‡‡‡‡‡‡‡‡‡Dana-Farber Cancer Institute, Boston, MA ∥∥∥∥∥∥∥∥∥∥∥∥∥Department of Medicine, Division of Medical Oncology, University of Colorado Anschutz Medical Campus, Aurora, CO ‡‡‡‡‡Department of Cancer Biology, Mayo Clinic, Jacksonville, FL ∥∥∥∥∥∥Department of Pathology and Laboratory Medicine, Indiana University, Indianapolis, IN ¶¶¶¶¶¶Cancer Immunotherapy Trials Network, Central Laboratory and Program in Immunology, Fred Hutchinson Cancer Research Center, Seattle, WA ††††††††††††Department of Pathology, New York University Langone Medical Centre ############New York University Medical School *************Perlmutter Cancer Center §§§§§§§§§§§§§Pulmonary Pathology, New York University Center for Biospecimen Research and Development, New York University ***************Department of Pathology, Memorial Sloan-Kettering Cancer Center ####Departments of Radiation Oncology and Pathology, Weill Cornell Medicine, New York, NY *****Department of Pathology, University of Texas M.D. Anderson Cancer Center, Houston, TX ∥∥∥∥∥∥∥∥∥∥∥∥Pathology Department, Stanford University Medical Centre, Stanford ∥∥∥∥∥∥∥∥∥∥∥∥∥∥Department of Pathology, Stanford University, Palo Alto ***Department of Pathology, School of Medicine, University of California, San Diego §§§§§§§§§§§§§§Research Pathology, Genentech Inc., South San Francisco, CA *************Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda ¶¶¶¶¶¶¶¶¶¶¶¶¶¶Translational Sciences, MedImmune, Gaithersberg, MD §§§§§§Academic Medical Innovation, Novartis Pharmaceuticals Corporation, East Hanover ##############Translational Medicine, Merck & Co. Inc., Kenilworth, NJ., Salgado R, Gevaert T, Russell PA, John T, Thapa B, Christie M, van de Vijver K, Estrada MV, Gonzalez-Ericsson PI, Sanders M, Solomon B, Solinas C, Van den Eynden GGGM, Allory Y, Preusser M, Hainfellner J, Pruneri G, Vingiani A, Demaria S, Symmans F, Nuciforo P, Comerma L, Thompson EA, Lakhani S, Kim SR, Schnitt S, Colpaert C, Sotiriou C, Scherer SJ, Ignatiadis M, Badve S, Pierce RH, Viale G, Sirtaine N, Penault-Llorca F, Sugie T, Fineberg S, Paik S, Srinivasan A, Richardson A, Wang Y, Chmielik E, Brock J, Johnson DB, Balko J, Wienert S, Bossuyt V, Michiels S, Ternes N, Burchardi N, Luen SJ, Savas P, Klauschen F, Watson PH, Nelson BH, Criscitiello C, O'Toole S, Larsimont D, de Wind R, Curigliano G, André F, Lacroix-Triki M, van de Vijver M, Rojo F, Floris G, Bedri S, Sparano J, Rimm D, Nielsen T, Kos Z, Hewitt S, Singh B, Farshid G, Loibl S, Allison KH, Tung N, Adams S, Willard-Gallo K, Horlings HM, Gandhi L, Moreira A, Hirsch F, Dieci MV, Urbanowicz M, Brcic I, Korski K, Gaire F, Koeppen H, Lo A, Giltnane J, Rebelatto MC, Steele KE, Zha J, Emancipator K, Juco JW, Denkert C, Reis-Filho J, Loi S, Fox SB
Publikováno v:
Advances in anatomic pathology [Adv Anat Pathol] 2017 Sep; Vol. 24 (5), pp. 235-251.
Autor:
Koeppen H; Genentech Inc., South San Francisco;, Yu W; Genentech Inc., South San Francisco;, Zha J; Crown Bioscience Inc., Jiangsu Province, China., Pandita A; OncoMDx, Inc., Palo Alto;, Penuel E; Genentech Inc., South San Francisco;, Rangell L; Genentech Inc., South San Francisco;, Raja R; Genentech Inc., South San Francisco;, Mohan S; OncoMDx, Inc., Palo Alto;, Patel R; Genentech Inc., South San Francisco;, Desai R; Genentech Inc., South San Francisco;, Fu L; Genentech Inc., South San Francisco;, Do A; Genentech Inc., South San Francisco;, Parab V; Genentech Inc., South San Francisco;, Xia X; Genentech Inc., South San Francisco;, Januario T; Genentech Inc., South San Francisco;, Louie SG; Genentech Inc., South San Francisco;, Filvaroff E; Genentech Inc., South San Francisco;, Shames DS; Genentech Inc., South San Francisco;, Wistuba I; Department of Translational Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas; and., Lipkind M; Genentech Inc., South San Francisco;, Huang J; Genentech Inc., South San Francisco;, Lazarov M; Gilead Sciences, Inc., Foster City, California;, Ramakrishnan V; Genentech Inc., South San Francisco;, Amler L; Genentech Inc., South San Francisco;, Phan SC; Genentech Inc., South San Francisco;, Patel P; Genentech Inc., South San Francisco;, Peterson A; Medivation, Inc., San Francisco;, Yauch RL; Genentech Inc., South San Francisco; bobyauch@gene.com.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2014 Sep 01; Vol. 20 (17), pp. 4488-98. Date of Electronic Publication: 2014 Mar 31.
Autor:
Pfanner N; Institut für Biochemie und Molekularbiologie, Zentrum für Biochemie und Molekulare Zellforschung, and 2 BIOSS Centre for Biological Signalling Studies, Universität Freiburg, 79104 Freiburg, Germany., van der Laan M, Amati P, Capaldi RA, Caudy AA, Chacinska A, Darshi M, Deckers M, Hoppins S, Icho T, Jakobs S, Ji J, Kozjak-Pavlovic V, Meisinger C, Odgren PR, Park SK, Rehling P, Reichert AS, Sheikh MS, Taylor SS, Tsuchida N, van der Bliek AM, van der Klei IJ, Weissman JS, Westermann B, Zha J, Neupert W, Nunnari J
Publikováno v:
The Journal of cell biology [J Cell Biol] 2014 Mar 31; Vol. 204 (7), pp. 1083-6.
Autor:
Del Nagro CJ; Discovery Oncology; Genentech; San Francisco, CA., Choi J; Discovery Oncology; Genentech; San Francisco, CA., Xiao Y; Discovery Oncology; Genentech; San Francisco, CA., Rangell L; Department of Pathology; Genentech; San Francisco, CA., Mohan S; Department of Research Diagnostics; Genentech; San Francisco, CA., Pandita A; Department of Research Diagnostics; Genentech; San Francisco, CA., Zha J; Department of Pathology; Genentech; San Francisco, CA., Jackson PK; Discovery Oncology; Genentech; San Francisco, CA., O'Brien T; Discovery Oncology; Genentech; San Francisco, CA.
Publikováno v:
Cell cycle (Georgetown, Tex.) [Cell Cycle] 2014; Vol. 13 (2), pp. 303-14. Date of Electronic Publication: 2013 Feb 01.
Autor:
Spigel DR; David R. Spigel, Thomas J. Ervin, and Davey B. Daniel, Sarah Cannon Research Institute; David R. Spigel, Tennessee Oncology, Nashville; Davey B. Daniel, Chattanooga Oncology Hematology Associates, Chattanooga, TN; Thomas J. Ervin, Florida Cancer Specialists, Fort Myers; Michael S. Wertheim, Hematology/Oncology Associates, Port St Lucie, FL; Rodryg A. Ramlau, Poznan University of Medical Sciences, Poznan; Maciej J. Krzakowski, Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland; Jerome H. Goldschmidt Jr, Blue Ridge Cancer Care, Christianburg, VA; George R. Blumenschein Jr, The University of Texas MD Anderson Cancer Center, Houston, TX; Gilles Robinet, University Hospital Morvan, Brest; Benoit Godbert, Centre Hospitalier Universitaire Nancy, Vandoeuvre-lès-Nancy; Fabrice Barlesi, Assistance Publique-Hôpitaux de Marseille, Aix Marseille University, Marseille, France; Ramaswamy Govindan, Washington University School of Medicine, St Louis, MO; Taral Patel, Mid Ohio Oncology/Hematology, Columbus, OH; Sergey V. Orlov, St Petersburg Pavlov State Medical University, St Petersburg, Russia; Wei Yu, Robert L. Yauch, Premal H. Patel, and See-Chun Phan, Genentech; Amy C. Peterson, Medivation, San Francisco, CA; and Jiping Zha, Crown Bioscience, Taicang City, China., Ervin TJ, Ramlau RA, Daniel DB, Goldschmidt JH Jr, Blumenschein GR Jr, Krzakowski MJ, Robinet G, Godbert B, Barlesi F, Govindan R, Patel T, Orlov SV, Wertheim MS, Yu W, Zha J, Yauch RL, Patel PH, Phan SC, Peterson AC
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2013 Nov 10; Vol. 31 (32), pp. 4105-14. Date of Electronic Publication: 2013 Oct 07.
An integrated genomic screen identifies LDHB as an essential gene for triple-negative breast cancer.
Autor:
McCleland ML; Departments of Pathology, Genentech, Inc, South San Francisco, California 94080, USA., Adler AS, Shang Y, Hunsaker T, Truong T, Peterson D, Torres E, Li L, Haley B, Stephan JP, Belvin M, Hatzivassiliou G, Blackwood EM, Corson L, Evangelista M, Zha J, Firestein R
Publikováno v:
Cancer research [Cancer Res] 2012 Nov 15; Vol. 72 (22), pp. 5812-23. Date of Electronic Publication: 2012 Nov 08.